There's a reason why INO has a market cap almost 60 times the size of Genticel (which makes Procervix for HPV)
Procervix has only been tested for regression from CIN 1 and achieved no better rate of regression than what happens naturally from CIN 1...INO's VGX-3100 achieved a rate of regression beyond what occurs naturally for CIN 2/3 (which Transgene, another former HPV contender, failed to achieve with its vaccine TG4100)
Since Procervix has not proven capable of preventing CIN 1 from progressing to CIN 2/3 any better than nature itself, it presents no threat to the CIN 2/3 market targeted by VGX-3100.
That is why Inovio has a $650M market cap based (only partly but substantially) on the statistically significant results achieved by VGX-3100 in both Phase I and Phase II trials, whereas tiny Genticel has only an $11M market cap based on the inconclusive results (in terms of efficacy, not safety) of just a Phase I trial for Procervix
And we continue to hear absurd claims that Procervix and Genticel are somehow a legit threat to VGX-3100 and INO...ridiculous
A) 83% and 49.5% measuring two different things, both good results
B) Scancell is a micro bio with a 69M market cap--ridiculous comparison
It was one of the top performing stocks on the three major exchanges for all of 2013
Close at A$1.26
Should be a new US all-time high in today's trading...we shall see
How is that opportunity back in the .70s a few short months ago looking now? pretty pretty good, I think...
Very well, factor in the dividend and Mart is up 8% over the last two years, compared to Sundance at a 48% gain (modified to reflect slight changes in price for both since my last post).
I having nothing personal against you, but you are consistently wrong about the facts on Sundance, so I point that out when you post. I already responded to your comparison and clearly Mart does not beat Sundance on every single issue used to value an oil company, because here Mart stands with a $432M market cap valuation, while Sundance is valued 27% higher with a $547M market cap.
Obviously the share count, boepd, updates, debt, and lack of dividend have not prevented Sundance from rising 48% in value over the last two years versus Mart only rising 8% (with dividends factored in). I have nothing particular against Mart or you, but it's pretty obvious that Sundance has proved a better investment so far and I expect that to continue. We shall see, and in any case good luck to you.
SDCJF -- Two years ago today it stood at .80, one year ago at 1.00, today at 1.19. The stock is up 19% from last year and 49% from two years ago.
MAUXF -- Two years ago today it stood at 1.55, one year ago at 1.39, today at 1.22. The stock is DOWN 12% from last year and 21% from two years ago.
Would rather have share price appreciation than a dividend or Mart's frequent updates trying to make its shareholders feel better about the sinking value of their investment.
Would rather have Sundance's obvious and explosive growth in the Eagle Ford in the good ole USA than park my money with Mart in freaking Africa. Yikes.
Some of us were buying INO at $2.00 to $3.00 per share as recently as a little over a year ago. That's how good it is, and it will get better.
It was there long enough for me to buy at .78 (after factoring in fees) and at 1.16 that gives me a 66% gain on my highest-priced position for sdcjf
You claimed at the time that you bought at that level, too (must have slipped your mind), so between you and me along, sounds like there was plenty of buying opportunity for anyone who was ready for it
not bad for a dog stock...woof woof
ntc I did actually take a tiny bit of profit today, selling about 4% of my position, but this is only the beginning for this rapidly growing company and I plan to be very much on board for the ride upward in share price over the next few years